Biocryst Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Biocryst Pharmaceuticals Inc
TickerBCRX
CIK #0000882796
CUSIP09058V103
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address2190 Parkway Lake Dr, Birmingham, AL 35244
Source [EDGAR]
CIK Filing 2011 - 2026
[0000882796] 10-K
[0000882796] 10-Q
[0000882796] 3
[0000882796] 4
[0000882796] 8-K
[0000882796] SC 13D
[0000882796] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Biocryst Pharmaceuticals Inc [2026-05-12] 0.0
Vanguard Capital Management LLC Biocryst Pharmaceuticals Inc [2026-04-29] 0.0
State Street Corp Biocryst Pharmaceuticals Inc [2026-02-09] 0.0
RA Capital Management LP Biocryst Pharmaceuticals Inc [2025-11-12] 0.0
Avoro Capital Advisors LLC Biocryst Pharmaceuticals Inc [2024-02-14] 6.4
State Street Corp Biocryst Pharmaceuticals Inc [2021-02-05] 6.26
Sarissa Capital Management LP Biocryst Pharmaceuticals Inc [2021-01-25] 5.0
Citadel Advisors LLC Biocryst Pharmaceuticals Inc [2020-06-10] 4.8
Adage Capital Partners GP LLC Biocryst Pharmaceuticals Inc [2020-04-17] 1.62
Point72 Asset Management LP Biocryst Pharmaceuticals Inc [2019-11-19] 6.0
Integrated Core Strategies US LLC Biocryst Pharmaceuticals Inc [2019-05-29] 5.6
Venrock Healthcare Capital Partners II LP Biocryst Pharmaceuticals Inc [2019-02-14] 5.8
Great Point Partners LLC Biocryst Pharmaceuticals Inc [2019-01-11] 6.95
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2018-04-02] 7.1
Great Point Partners LLC Biocryst Pharmaceuticals Inc [2018-02-16] 7.6
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2018-02-14] 7.1
Janus Henderson Group PLC Biocryst Pharmaceuticals Inc [2018-02-12] 6.8
Vanguard Group Inc Biocryst Pharmaceuticals Inc [2018-02-08] 5.87
Flynn James E Biocryst Pharmaceuticals Inc [2017-06-05] 6.81
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2017-03-06] 5.0
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2017-01-09] 5.0
RTW Investments LLC Biocryst Pharmaceuticals Inc [2016-08-26] 5.02
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2016-08-22] 5.1
Baker Bros Advisors LP Biocryst Pharmaceuticals Inc [2016-08-17] 14.95
Flynn James E Biocryst Pharmaceuticals Inc [2016-08-12] 6.64
Venrock Healthcare Capital Partners LP Biocryst Pharmaceuticals Inc [2016-03-28] 7.1
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2016-03-14] 5.1
Baker Bros Advisors LP Biocryst Pharmaceuticals Inc [2015-11-06] 19.5
BlackRock Inc Biocryst Pharmaceuticals Inc [2015-02-02] 7.6
Baker Julian Biocryst Pharmaceuticals Inc [2014-02-25] 11.3
Wellington Management Co LLP Biocryst Pharmaceuticals Inc [2014-02-14] 8.11
FMR LLC Biocryst Pharmaceuticals Inc [2014-02-10] 0.0
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2013-08-09] 0.9
RTW Investments LLC Biocryst Pharmaceuticals Inc [2013-08-02] 5.1
BlackRock Inc Biocryst Pharmaceuticals Inc [2013-01-30] 6.16
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2012-03-16] 6.5
Form 3/4/5 Filer 2011 - 2026
Milano Vincent
Biocryst Pharmaceuticals Inc
Sanders Machelle
Milne Jill C
Galson Steven K
Levin Alan G
Frank Steven
Heggie Theresa
McKee Amy E
Stonehouse Jon P
Barnes Alane P
Menon Sandeep
Dullinger Ronald
Gayer Charles K
Ghias Babar
Hutson Nancy J
Thackray Helen M
Doyle Anthony
Abercrombie George B
Aselage Steve
Lee Kenneth B Jr
Ingram Robert Alexander
Jones Michael L
Babu Yarlagadda S
Sheridan William P
Sniecinski Megan
Staab Thomas R II
Powell Lynne
Erck Stanley C
Cohen Fred E
Patel Sanj K
Baker Bros Advisors GP LLC
Baker Julian
Baker Felix
Baker Bros Advisors LP
Sanders Charles A
Jensen Peder
Baker Bros Investments LP
Baker Brothers Life Sciences LP
Baker/Tisch Investments LP
667 LP
14159 LP
Baker Bros Investments II LP
Higgins John L
Horovitz ZOLA P
Lowrey Robert S
McCullough David
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Heggie Theresa
Common Stock
2026-03-20 Sell 49,933 $10.11 504,823
Heggie Theresa
Automatic Stock Option Grant · derivative
2026-03-20 Option exercise 49,933 $0.00
Heggie Theresa
Common Stock
2026-03-20 Option exercise 49,933 $6.30 314,578
Barnes Alane P
Emp. Stock Option (Right to Buy) · derivative
2026-03-16 Option exercise 150,000 $0.00
Barnes Alane P
Common Stock
2026-03-16 Sell 150,000 $9.15 1,372,500
Barnes Alane P
Common Stock
2026-03-16 Option exercise 150,000 $5.51 826,500
Stonehouse Jon P
Common Stock
2026-03-02 Disposed to issuer 305,995 $8.64 2,643,797
Stonehouse Jon P
Common Stock
2026-03-02 Option exercise 305,995 $3.22 985,304
Stonehouse Jon P
Emp. Stock Option (Right to Buy) · derivative
2026-03-02 Option exercise 305,995 $0.00
McKee Amy E
Common Stock
2026-02-27 Grant 642 $8.75 5,618
Stonehouse Jon P
Common Stock
2026-02-27 Grant 421 $8.75 3,684
Milne Jill C
Common Stock
2026-02-27 Grant 528 $8.75 4,620
Frank Steven
Common Stock
2026-02-27 Grant 1,285 $8.75 11,244
Milano Vincent
Common Stock
2026-02-27 Grant 848 $8.75 7,420
Milne Jill C
Common Stock
2026-01-23 Grant 2,582
Milne Jill C
Automatic Stock Option Grant · derivative
2026-01-23 Grant 26,684 $0.00
Milne Jill C
Common Stock
2026-01-23 Grant 12,272 $0.00
Gayer Charles K
Common Stock
2025-12-22 Option exercise 50,000 $5.51 275,500
Gayer Charles K
Common Stock
2025-12-22 Option exercise 10,091 $5.04 50,859
Gayer Charles K
Emp. Stock Option (Right to Buy) · derivative
2025-12-22 Option exercise 50,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 303 246,000,731
2025-12-31 276 210,842,185
2025-09-30 287 192,571,403
2025-06-30 296 194,527,112
2025-03-31 277 171,694,502
2024-12-31 260 165,893,260
2024-09-30 261 168,961,124
2024-06-30 243 170,085,214
2024-03-31 240 184,213,863
2023-12-31 236 180,356,383
2023-09-30 235 172,178,939
2023-06-30 238 169,420,090
Form 13F Holdings
Firm Period DFND Voting Shares
Wedge Capital Management L L P/NC [2026-06-30] SOLE 123,685 380,801
Doliver Advisors LP [2026-06-30] SOLE 0 374,328
Assenagon Asset Management SA [2026-06-30] SOLE 353,044 353,044
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 112,893 112,893
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 3,621 65,149
Grimes & Company Inc [2026-06-30] SOLE 25,298 46,850
Empirical Financial Services LLC DBA Empirical Wealth Ma [2026-06-30] SOLE 39,365 40,895
Cypress Wealth Services LLC [2026-06-30] SOLE 0 20,000
Curated Wealth Partners LLC [2026-06-30] OTR 0 20,000
Merit Financial Group LLC [2026-06-30] OTR 0 15,893
Steel Peak Wealth Management LLC [2026-06-30] SOLE 0 13,741
Alaska Retirement Management Board [2026-06-30] SOLE 11,899 11,899
Union Bancaire Privee UBP SA [2026-06-30] DFND 10,000 10,000
Farther Finance Advisors LLC [2026-06-30] SOLE 0 6,551
Merit Financial Group LLC [2026-06-30] SOLE 0 3,292
IFP Advisors LLC [2026-06-30] SOLE 3,243 3,243
Versant Capital Management Inc [2026-06-30] SOLE 2,003 2,003
Activest Wealth Management [2026-06-30] SOLE 0 2,000
Gamma Investing LLC [2026-06-30] DFND 1,229 1,229
True Wealth Design LLC [2026-06-30] SOLE 0 946
Empirical Financial Services LLC DBA Empirical Wealth Ma [2026-06-30] OTR 835 835
Independence Bank of Kentucky [2026-06-30] SOLE 225 225
Salem Investment Counselors Inc [2026-06-30] SOLE 0 200
Arlington Trust Co LLC [2026-06-30] SOLE 150 150
Hughes Financial Services LLC [2026-06-30] SOLE 2 2
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com